We found that high expression of MKI67 was correlated with poor differentiation, TNM classification, and classification in BRCA patients (46–48), and high expression of MKI67 was closely related to BCLA stage, Edmondson grade, tumor size, and tumor nodule increase in LIHC patients (49). The gene discussed is MKI67; the disease is neoplasm.